AIM Rule 17 Schedule 2(g) Update

RNS Number : 5935G

Induction Healthcare Group PLC

30 March 2022

 

30 March 2022

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

AIM Rule 17 Schedule 2(g) Update

Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces the following information relating to directors' disclosure under Schedule Two, paragraph (g) of the AIM Rules for Companies:

Chris Spencer, non-executive Chairman, has been a director of a private company, Acea Health Limited, since 2 April 2018.  On 29 March 2022, Acea Health Limited entered into creditors voluntary liquidation.

ENQUIRIES

Induction James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer	Via Walbrook PR Ltd: [e-mail]
Singer Capital Markets (Nominated Adviser and Broker)	[phone]
Philip Davies / Kailey Aliyar
Walbrook PR Ltd	[e-mail]
Paul McManus / Stephanie Cuthbert	Mob: [phone]

About Induction -   www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve . Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.  

 

END

 

 

MSCBKKBQCBKKCNN